| 26.04.2024 20:59 | ALTN, FSV, BISI | EARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters Germany | Alliance |
| 26.04.2024 07:00 | ROQ | Annual Report & Financial Statements - 31 Dec 2023 | RNS |
| 05.04.2024 12:32 | ROQ | IN BRIEF: Roquefort cancels fundraise after "unusual" stock movements | Alliance |
| 05.04.2024 07:00 | ROQ | Response to Share Price Movement | RNS |
| 11.03.2024 11:12 | ROQ | Roquefort celebrates "significant milestones" in cancer research | Alliance |
| 11.03.2024 07:00 | ROQ | Positive Results: Midkine mRNA and STAT-6 siRNA | RNS |
| 06.02.2024 16:50 | ROQ | IN BRIEF: Roquefort hails further MK studies, licence talks continue | Alliance |
| 24.11.2023 07:00 | ROQ | Change of Auditor | RNS |
| 06.11.2023 12:01 | ROQ | Roquefort Therapeutics MK cell programme shows positive results | Alliance |
| 06.11.2023 07:00 | ROQ | Significant Mesodermal Killer Cell Milestone | RNS |
| 27.09.2023 15:43 | ROQ, NARF, AMIF | EARNINGS: Biome loss widens; Amicorp focused on growth post-IPO | Alliance |
| 27.09.2023 07:00 | ROQ | Interim Results to 30 June 2023 | RNS |
| 22.09.2023 11:42 | ROQ | Investor Presentation via Investor Meet Company | Reach |
| 14.08.2023 11:07 | ROQ | Roquefort files patent application for mRNA and RNA therapies | Alliance |
| 14.08.2023 07:00 | ROQ | Expansion of Patent Portfolio | RNS |
| 07.08.2023 11:04 | ROQ | IN BRIEF: Roquefort announces new sirNA sequences and patent filing | Alliance |
| 07.08.2023 07:00 | ROQ | Development of New Novel siRNA Therapeutics | RNS |
| 02.08.2023 07:00 | ROQ | Director/PDMR Shareholding | RNS |
| 12.07.2023 10:27 | ROQ | Director/PDMR Shareholding | RNS |
| 29.06.2023 18:51 | LST, ROQ, LIKE | TRADING UPDATES: Anpario trading in line, Likewise Group sales rise | Alliance |
| 29.06.2023 10:05 | ROQ | Results of AGM | RNS |
| 29.06.2023 07:00 | ROQ | AGM Statement | RNS |
| 27.06.2023 07:00 | ROQ | Investor Presentation via Investor Meet Company | Reach |
| 26.06.2023 14:41 | ROQ | Director/PDMR Shareholding | RNS |
| 26.06.2023 10:36 | ROQ | Director/PDMR Shareholding | RNS |
| 26.06.2023 10:00 | ROQ | Director/PDMR Shareholding | RNS |
| 22.06.2023 20:34 | FMET, ROQ, TLOU | TRADING UPDATES: Plant Health Care announces GBP2.8 million fundraise | Alliance |
| 22.06.2023 15:44 | VRCI, TRR, TXP | UK shareholder meetings calendar - next 7 days | Alliance |
| 22.06.2023 07:00 | ROQ | RNA Medicine Shows In Vitro Anti-Cancer Efficacy | RNS |
| 19.06.2023 12:28 | ROQ | Roquefort Therapeutics celebrates cancer antibody trial results | Alliance |
| 19.06.2023 07:00 | ROQ | Antibody Program Results & Orphan Drug Indication | RNS |
| 13.06.2023 11:52 | ROQ | IN BRIEF: Roquefort says anti-cancer mRNA study shows positive results | Alliance |
| 13.06.2023 07:00 | ROQ | Anti-Cancer MDK mRNA - Positive in vitro Results | RNS |
| 07.06.2023 14:41 | ROQ | IN BRIEF: Roquefort Therapeutics suspension on shares lifted | Alliance |
| 07.06.2023 10:11 | ROQ | Restoration of Trading | RNS |
| 06.06.2023 07:00 | ROQ | Notice of Annual General Meeting | RNS |
| 05.06.2023 11:50 | ROQ | Roquefort Therapeutics loss widens as administrative costs go up | Alliance |
| 05.06.2023 07:00 | ROQ | Annual Report & Financial Statements - 31 Dec 2022 | RNS |
| 02.05.2023 07:56 | ROQ | Suspension of Trading Pending 2022 Annual Report | RNS |
| 02.05.2023 07:30 | ROQ | Suspension - Roquefort Therapeutics plc | RNS |
| 13.03.2023 12:18 | VRCI, CSFS, SCLP | SUMMARY: London listings with exposure to Silicon Valley Bank | Alliance |
| 13.03.2023 07:30 | ROQ | Confirmation of No Exposure to Silicon Valley Bank | RNS |
| 08.03.2023 14:29 | ROQ | IN BRIEF: Roquefort Therapeutics announces new anti-cancer platform | Alliance |
| 08.03.2023 07:00 | ROQ | Creation of New Novel Family of mRNA Therapeutics | RNS |
| 06.03.2023 16:27 | ROQ | IN BRIEF: Roquefort Therapeutics sets up scientific advisory board | Alliance |
| 06.03.2023 07:00 | ROQ | Formation of Scientific Advisory Board | RNS |
| 01.03.2023 07:00 | ROQ | Company Presentation | Reach |
| 21.02.2023 07:00 | ROQ | Investor Presentation | Reach |
| 20.02.2023 14:06 | ROQ | Roquefort signs GBP5 million deal with Randox for Midkine portfolio | Alliance |
| 20.02.2023 07:00 | ROQ | Randox Licence and Royalty Agreement | RNS |
| 24.01.2023 14:48 | ROQ, NET, ACRL | TRADING UPDATES: Accrol builds paper mill; Netcall interim revenue up | Alliance |
| 24.01.2023 07:00 | ROQ | MDK Oncology Antibodies Demonstrate In-Vivo Safety | RNS |
| 18.01.2023 08:36 | ROQ | Holding(s) in Company | RNS |
| 16.01.2023 07:00 | ROQ | Appointment of Auditor | RNS |
| 09.01.2023 14:17 | ROQ | Roquefort shares up as busy year-end prompts optimistic outlook | Alliance |
| 09.01.2023 07:00 | ROQ | Operations Update | RNS |
| 05.12.2022 08:07 | ROQ | Presentation of Midkine Oligonucleotide Program | Reach |
| 01.12.2022 14:00 | ROQ | Resignation of Auditor | RNS |
| 25.10.2022 07:00 | ROQ | Midkine Antibody Program - Festival of Biologics | Reach |
| 11.10.2022 13:14 | ROQ | IN BRIEF: Roquefort Therapeutics sees positive results in cancer study | Alliance |
| 11.10.2022 07:00 | ROQ | ROQ Presents Study Results at the ESGCT Conference | Reach |
| 28.09.2022 07:00 | ROQ | Director/PDMR Shareholding | RNS |
| 26.09.2022 14:30 | ROQ | Director/PDMR Shareholding | RNS |
| 23.09.2022 09:28 | ROQ | Roquefort Therapeutics losses widen but boasts strong cash balance | Alliance |
| 23.09.2022 07:00 | ROQ | Interim Results to 30 June 2022 | RNS |
| 16.09.2022 09:40 | ROQ | Roquefort Therapeutics completes Oncogeni deal for GBP5.5 million | Alliance |
| 16.09.2022 08:00 | ROQ | Investor Presentation | Reach |
| 16.09.2022 07:01 | ROQ | Board and Management Appointments | RNS |
| 16.09.2022 07:00 | ROQ | Acquisition Completion, Admission & Voting Rights | RNS |
| 15.09.2022 12:26 | ROQ | Notice of Admission | RNS |
| 13.09.2022 11:08 | ROQ | Publication of Prospectus | RNS |
| 11.08.2022 19:06 | ROQ | IN BRIEF: Roquefort pleased with MDK in vitro experiments | Alliance |
| 11.08.2022 07:00 | ROQ | Pre-clinical Program & Transaction Update | RNS |
| 20.07.2022 07:00 | ROQ | Appointment of Joint Broker | RNS |
| 15.07.2022 21:26 | MAFL, IRON, N4P | TRADING UPDATES: Premier Miton assets dip; Challenger Energy CFO quits | Alliance |
